Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) |
Lupus Erythematosus, Systemic, Lupus Nephritis | Phase2 | Australia Austria Brazil Czechia Denmark France Germany Hungary Israel Italy Japan Netherlands Norway Romania Saudi Arabia Singapore South Korea Spain Sweden Switzerland Taiwan United Kingdom United States View all |
NCT06581198 |
Home Reported Outcomes in PNH |
Paroxysmal Nocturnal Hemoglobinuria | United States | NCT06411626 | |
A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever |
Dengue | Phase2 | Brazil Colombia India Malaysia Singapore Vietnam View all |
NCT06006559 |
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN |
Glomerulonephritis, IGA, Immunoglobulin A Nephropathy | Phase2 | Argentina Israel Malaysia United States View all |
NCT06797518 |
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas |
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant, Prostatic Neoplasms, Castration-Resistant, Endometrial Cancer, Ovarian Clear Cell Carcinoma, Metastatic Castration-resistant Prostate Cancer | Phase1, Phase2 | France Italy Poland South Korea Spain United Kingdom United States View all |
NCT04104776 |
Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants |
Alzheimer Disease, Mild Cognitive Impairment | Phase1 | France Spain |
NCT05469360 |
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC |
Prostate Cancer | Phase3 | Australia Brazil China Hong Kong India Japan Singapore South Korea Taiwan United Kingdom United States View all |
NCT06855277 |
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
Early Breast Cancer | Phase3 | Argentina Australia Brazil Canada China Germany Hong Kong Israel Mexico Portugal Puerto Rico South Korea Taiwan Turkey (Türkiye) United States View all |
NCT05827081 |
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study |
Relapsing Multiple Sclerosis | Portugal | NCT05809986 | |
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
Prostate Cancer | Phase4 | Austria Belgium Canada Czechia France Germany Netherlands Spain Sweden United Kingdom United States View all |
NCT05803941 |